The global post-operative nausea and vomiting (PONV) market is growing at a significant rate due to bourgeoning incidence rate of post-operative complications and increasing demand for combination therapy, as well as introduction of promising drugs in this segment across the globe.

Scope of the Report:

Major factors boosting the growth of the post-operative nausea and vomiting market include large number of surgeries performed and rise in the rate of postoperative complications, such as, dizziness, vomiting, and nausea. However, strict regulatory approvals and high health care expenditure are predicted to hamper the growth of the PONV market during the forecast period.

The global Postoperative Nausea and Vomiting (PONV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Postoperative Nausea and Vomiting (PONV).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Postoperative Nausea and Vomiting (PONV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Postoperative Nausea and Vomiting (PONV) market by product type and applications/end industries.

Market Segment by Companies, this report covers

Acacia Pharma

F. Hoffmann-La Roche

Novartis

Ani Pharmaceuticals

Camurus

Sanofi

Helsinn Holding

Eisai

Merck

GlaxoSmithKline

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Serotonin Antagonists

Steroids

Dopamine Antagonists

NK-1 Receptor Antagonists

Others

Non-pharmacologic Treatment

Market Segment by Applications, can be divided into

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies and Drug Stores

Table of Contents

1 Postoperative Nausea and Vomiting (PONV) Market Overview

1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV)

1.2 Classification of Postoperative Nausea and Vomiting (PONV) by Types

1.2.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Comparison by Types (2017-2023)

1.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Types in 2017

1.2.3 Serotonin Antagonists

1.2.4 Steroids

1.2.5 Dopamine Antagonists

1.2.6 NK-1 Receptor Antagonists

1.2.7 Others

1.2.8 Non-pharmacologic Treatment

1.3 Global Postoperative Nausea and Vomiting (PONV) Market by Application

1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Online Pharmacies

1.3.4 Retail Pharmacies and Drug Stores

1.4 Global Postoperative Nausea and Vomiting (PONV) Market by Regions

1.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2013-2023)

1.5 Global Market Size of Postoperative Nausea and Vomiting (PONV) (2013-2023)

2 Manufacturers Profiles

2.1 Acacia Pharma

2.1.1 Business Overview

2.1.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.2 F. Hoffmann-La Roche

2.2.1 Business Overview

2.2.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ani Pharmaceuticals

2.4.1 Business Overview

2.4.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Camurus

2.5.1 Business Overview

2.5.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Helsinn Holding

2.7.1 Business Overview

2.7.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Eisai

2.8.1 Business Overview

2.8.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Merck

2.9.1 Business Overview

2.9.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

2.10 GlaxoSmithKline

2.10.1 Business Overview

2.10.2 Postoperative Nausea and Vomiting (PONV) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Postoperative Nausea and Vomiting (PONV) Market Competition, by Players

3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Postoperative Nausea and Vomiting (PONV) Players Market Share

3.2.2 Top 10 Postoperative Nausea and Vomiting (PONV) Players Market Share

3.3 Market Competition Trend

4 Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions

4.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Regions

4.2 North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.3 Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.5 South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries

5.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

5.2 USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5.3 Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

5.4 Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries

6.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

6.2 Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.3 UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.4 France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.5 Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

6.6 Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries

7.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

7.2 China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.3 Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.4 Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.5 India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries

8.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

8.2 Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8.3 Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

8.4 Colombia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Postoperative Nausea and Vomiting (PONV) by Countries

9.1 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.3 UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.4 Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

9.6 South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2013-2018)

10 Global Postoperative Nausea and Vomiting (PONV) Market Segment by Type

10.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2013-2018)

10.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Type (2018-2023)

10.3 Serotonin Antagonists Revenue Growth Rate (2013-2023)

10.4 Steroids Revenue Growth Rate (2013-2023)

10.5 Dopamine Antagonists Revenue Growth Rate (2013-2023)

10.6 NK-1 Receptor Antagonists Revenue Growth Rate (2013-2023)

10.7 Others Revenue Growth Rate (2013-2023)

10.8 Non-pharmacologic Treatment Revenue Growth Rate (2013-2023)

11 Global Postoperative Nausea and Vomiting (PONV) Market Segment by Application

11.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2013-2018)

11.2 Postoperative Nausea and Vomiting (PONV) Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Online Pharmacies Revenue Growth (2013-2018)

11.5 Retail Pharmacies and Drug Stores Revenue Growth (2013-2018)

12 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)

12.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2018-2023)

12.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Regions (2018-2023)

12.3 North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.4 Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.6 South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Postoperative Nausea and Vomiting (PONV) Picture

Table Product Specifications of Postoperative Nausea and Vomiting (PONV)

Table Global Postoperative Nausea and Vomit